California Public Employees Retirement System lowered its holdings in LeMaitre Vascular Inc (NASDAQ:LMAT) by 5.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 49,641 shares of the medical instruments supplier’s stock after selling 2,642 shares during the period. California Public Employees Retirement System’s holdings in LeMaitre Vascular were worth $1,581,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also bought and sold shares of LMAT. Victory Capital Management Inc. boosted its holdings in LeMaitre Vascular by 181.2% in the 3rd quarter. Victory Capital Management Inc. now owns 4,139 shares of the medical instruments supplier’s stock valued at $155,000 after purchasing an additional 2,667 shares during the period. Royal Bank of Canada raised its position in shares of LeMaitre Vascular by 856.5% in the 2nd quarter. Royal Bank of Canada now owns 5,031 shares of the medical instruments supplier’s stock valued at $157,000 after buying an additional 4,505 shares in the last quarter. BB&T Corp acquired a new position in shares of LeMaitre Vascular in the 4th quarter valued at approximately $202,000. Advisor Group Inc. raised its position in shares of LeMaitre Vascular by 119.1% in the 3rd quarter. Advisor Group Inc. now owns 5,483 shares of the medical instruments supplier’s stock valued at $205,000 after buying an additional 2,980 shares in the last quarter. Finally, Hartford Investment Management Co. acquired a new position in shares of LeMaitre Vascular in the 3rd quarter valued at approximately $231,000. 72.76% of the stock is owned by hedge funds and other institutional investors.
Several equities analysts have recently commented on LMAT shares. BidaskClub upgraded shares of LeMaitre Vascular from a “hold” rating to a “buy” rating in a research report on Wednesday, February 7th. Zacks Investment Research upgraded shares of LeMaitre Vascular from a “hold” rating to a “buy” rating and set a $40.00 target price for the company in a research report on Wednesday, February 28th. Finally, Canaccord Genuity restated a “hold” rating and issued a $33.00 target price on shares of LeMaitre Vascular in a research report on Friday, February 23rd. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. LeMaitre Vascular presently has an average rating of “Hold” and a consensus price target of $34.00.
LeMaitre Vascular Inc (NASDAQ LMAT) opened at $35.84 on Monday. The company has a market cap of $691.03, a P/E ratio of 42.16, a PEG ratio of 2.45 and a beta of 0.55. LeMaitre Vascular Inc has a 12-month low of $22.95 and a 12-month high of $39.88.
LeMaitre Vascular (NASDAQ:LMAT) last issued its earnings results on Wednesday, February 21st. The medical instruments supplier reported $0.21 EPS for the quarter, beating the consensus estimate of $0.20 by $0.01. The company had revenue of $26.15 million during the quarter, compared to analysts’ expectations of $26.23 million. LeMaitre Vascular had a net margin of 17.03% and a return on equity of 16.93%. The business’s revenue for the quarter was up 12.3% compared to the same quarter last year. During the same period in the previous year, the company earned $0.13 EPS. equities research analysts forecast that LeMaitre Vascular Inc will post 0.98 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 5th. Investors of record on Thursday, March 22nd will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.78%. This is a boost from LeMaitre Vascular’s previous quarterly dividend of $0.06. The ex-dividend date is Wednesday, March 21st. LeMaitre Vascular’s dividend payout ratio is currently 32.94%.
LeMaitre Vascular Company Profile
LeMaitre Vascular, Inc is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.
Want to see what other hedge funds are holding LMAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LeMaitre Vascular Inc (NASDAQ:LMAT).
Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.